Back to search

Article

Targeting Chronic Lymphocytic Leukemia With DNA Nanoparticles

2013-11-15

Abstract excerpt

Abstract A significant challenge in many areas of cancer research and treatment is the lack of cancer cell-specific binding agents. In Chronic Lymphocytic Leukemia (CLL), numerous genetic and molecular markers are used to divide patients into prognostic categories but clearly distinguished etiological or biological subtypes remain elusive. The current targeted treatments for CLL include monoclonal antibodies: alem...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52d2511c-4359-5628-95cb-92769c54ed4c
DOI
10.1182/blood.v122.21.1623.1623
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Chronic Lymphocytic Leukemia With DNA NanoparticlesDOI 10.1182/blood.v122.21.1623.1623
Select a neighboring publication to make it the new centre.